Abstract
Several hybrid viral gene transfer systems have been described that exploit the favorable features of the two parent viral species. We have developed a hybrid adeno-retroviral vector system to generate a retroviral vector in situ. The system consists of adenoviruses encoding MoMLV gag.pol (Axtet.gag.pol), the VSV-G viral envelope (Axtet.VSV-G), the retroviral vector LXSN expressing the neomycin phosphotransferase gene (AV-LXSN) and a transcriptional regulator to control expression of gag.pol and envelope (AV-rtTA). In vitro, biologically active retroviral vector preparations were generated following adeno-retroviral transduction of 9L rat glioma cells. In vivo the transcomplementing adeno-retroviruses were co-administered intratumorally into subcutaneous 9L glioma tumors in rats and human A375 melanoma xenografts in nude mice. In the 9L rat model, G418R cell cultures were only obtained when 9L cells were harvested from tumors injected with all four transcomplementing adeno-retroviruses. Molecular analysis of DNA extracted from 9L G418R populations derived both in vitro and in vivo showed appropriate integration of the LXSN proviral sequence. Tumor cells were harvested 1, 3 and 4 weeks after adeno-retrovirus administration to the human A375 xenografts. The percentage of G418R colonies recovered from tumors transduced with all of the transcomplementing adeno-retroviruses increased with time, whereas no increase was observed in tumors transduced with AV-LXSN alone. DNA extracted from G418R A375 cell populations showed the presence of integrated proviral sequences only in animals that received the full complement of adeno-retroviruses. These results demonstrate that adenoviral vectors expressing transcomplementing genes for retroviral proteins and retroviral vector RNAs can be used for in situ transduction of target cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fisher K et al. A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome Hum Gene Ther 1996 7: 2079–2087
Wang S, Vos J-M . A hybrid Herpesvirus infectious vector based on Epstein–Barr virus and Herpes Simplex virus type 1 for gene transfer into human cells in vitro and in vivo J Virol 1996 70: 8422–8430
Li K, Garoff H . Production of infectious recombinant Moloney murine leukemia virus particles in BHK cells using Semliki Forest virus-derived RNA expression vectors Proc Natl Acad Sci USA 1996 93: 11658–11663
Johnston KM et al. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells Hum Gene Ther 1997 8: 359–370
Fraefel C et al. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors Mol Med 1997 3: 813–825
Walfors J, Xanthopoulos KG, Morgan RA . Semliki forest virus-mediated production of retroviral vector RNA in retroviral packaging cells Human Gene Ther 1997 8: 2031–2041
Feng M et al. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector Nat Biotech 1997 15: 866–870
Ramsey WJ et al. Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors Biochem Biophys Res Commun 1998 246: 912–919
Giard DJ et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors J Natl Cancer Inst 1973 51: 1417–1423
Gershwin ME et al. Immunobiology of heterotransplanted human tumors in nude mice J Natl Cancer Inst 1977 58: 1455–1463
Hallenbeck PL et al. Replication of E1 deleted adenoviral gene therapy vectors in tumor cell lines (submitted for publication)
Culver KW et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors Science 1992 256: 1550–1552
Ram Z et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells Nature Med 1997 3: 1354–1361
Yoshida Y, Hamada H . Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal Biochem Biophys Res Commun 1997 230: 426–430
Yoshida Y, Emi N, Hamada H . VSV-G-pseudotyped retroviral packaging through adenovirus-mediated inducible gene expression Biochem Biophys Res Commun 1997 232: 379–382
Fishman GI, Kaplan M, Buttrick PM . Tetracycline-regulated cardiac gene expression in vivo J Clin Invest 1994 93: 1864–1868
McGrory WJ, Bautista DS, Graham FL . A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5 Virology 1988 163: 614–617
Graham FL, Prevec L . Adenovirus-based expression vectors and recombinant vaccines Biotechnology 1992 20: 363–390
Okada T et al. Development of long lasting anti-tumor immunity followed by thymidine kinase-mediated killing of rat experimental glioma (submitted for publication)
Barth RJJ et al. Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes J Immunol 1990 144: 1531–1537
Acknowledgements
We wish to thank J Jagadeesh for technical assistance, Julie Lekstrom-Himes for providing pAV-rtTA and M Shah for access to unpublished data and R Morgan for advice, support and a critical appraisal of this manuscript. NJC is supported by a NIH, Fogarty Fellowship.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Caplen, N., Higginbotham, J., Scheel, J. et al. Adeno-retroviral chimeric viruses as in vivo transducing agents. Gene Ther 6, 454–459 (1999). https://doi.org/10.1038/sj.gt.3300835
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300835
Keywords
This article is cited by
-
Foamy virus–adenovirus hybrid vectors
Gene Therapy (2004)
-
Post-mitotic, differentiated myotubes efficiently produce retroviral vector from hybrid adeno-retrovirus templates
Gene Therapy (2001)
-
Genomic integration and gene expression by a modified adenoviral vector
Nature Biotechnology (2000)